Ovarian Cancer Treatments Strategy: Focus on PARP Inhibitors and Immune Check Point Inhibitors

SIMPLE SUMMARY: Ovarian cancer treatment is the deadliest of gynecological cancers but the introduction of target therapies in its therapeutic algorithm has significantly improved outcomes. The aim of this article was to provide a review of completed and ongoing clinical trials involving the use of...

Descripción completa

Detalles Bibliográficos
Autores principales: Nero, Camilla, Ciccarone, Francesca, Pietragalla, Antonella, Duranti, Simona, Daniele, Gennaro, Salutari, Vanda, Carbone, Maria Vittoria, Scambia, Giovanni, Lorusso, Domenica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7999042/
https://www.ncbi.nlm.nih.gov/pubmed/33803954
http://dx.doi.org/10.3390/cancers13061298

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7999042/
https://www.ncbi.nlm.nih.gov/pubmed/33803954
http://dx.doi.org/10.3390/cancers13061298

Ejemplares similares